PortfoliosLab logo
granolas
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GSK 9.09%NESN.SW 9.09%ASML 9.09%NOVN.SW 9.09%NVO 9.09%MC.PA 9.09%AZN.L 9.09%SAP.DE 9.09%SAN.PA 9.09%RMS.PA 9.09%RHHBY 9.09%EquityEquity

Performance

Performance Chart


Loading data...

The earliest data available for this chart is Jul 11, 2001, corresponding to the inception date of RHHBY

Returns By Period

As of May 18, 2025, the granolas returned 9.48% Year-To-Date and 12.38% of annualized return in the last 10 years.


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
1.30%12.79%1.49%12.35%15.12%10.89%
granolas9.48%6.37%10.50%-2.19%13.72%12.38%
GSK
GlaxoSmithKline plc
13.84%5.97%15.44%-12.60%7.29%6.21%
NESN.SW
Nestlé S.A.
29.11%-0.33%22.53%0.64%1.86%5.66%
ASML
ASML Holding N.V.
8.47%17.19%14.15%-18.38%20.18%21.55%
NOVN.SW
Novartis AG
15.20%-1.27%9.47%10.07%10.31%6.42%
NVO
Novo Nordisk A/S
-23.96%10.83%-35.71%-50.22%16.52%10.39%
MC.PA
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
-13.22%3.39%-6.74%-32.30%9.91%13.40%
AZN.L
AstraZeneca plc
6.23%2.11%10.51%-8.97%7.33%10.39%
SAP.DE
SAP SE
21.94%16.67%30.92%55.84%22.39%15.99%
SAN.PA
Sanofi
10.21%3.69%11.14%10.36%5.52%3.98%
RMS.PA
Hermès International Société en commandite par actions
21.23%11.92%35.94%16.83%30.80%22.76%
RHHBY
Roche Holding AG
15.62%0.33%12.52%22.91%0.44%3.81%
*Annualized

Monthly Returns

The table below presents the monthly returns of granolas, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20258.30%3.63%-3.51%1.00%0.10%9.48%
20244.29%2.71%2.89%-2.72%4.17%1.00%0.70%6.42%-3.97%-7.65%-4.18%-1.77%0.91%
20237.22%-3.68%9.72%5.20%-3.10%2.98%0.62%-1.93%-4.33%-2.93%7.31%4.13%21.80%
2022-6.11%-1.63%2.88%-3.25%-1.74%-4.84%7.78%-9.17%-7.21%8.48%13.15%-1.17%-5.27%
2021-1.10%-1.03%3.43%7.59%5.52%2.85%2.86%1.98%-6.34%7.96%-1.83%5.05%29.28%
2020-1.13%-6.65%-1.28%7.33%5.14%3.04%1.56%2.48%-1.04%-7.69%10.22%4.91%16.49%
20194.78%4.82%4.99%1.50%-2.55%8.34%-0.61%1.18%1.89%4.78%2.17%3.88%40.78%
20184.17%-5.27%2.39%1.98%1.11%-1.40%7.22%0.11%-0.11%-5.20%1.80%-4.02%2.04%
20172.30%3.48%5.33%3.35%6.93%-1.07%-0.10%2.66%2.87%-0.21%0.24%0.73%29.60%
2016-2.29%-2.84%3.39%1.42%2.33%-0.03%7.14%-3.90%-0.68%-5.20%-2.54%4.05%0.13%
20150.27%4.44%1.55%3.47%0.99%-4.42%4.23%-6.36%-1.80%5.59%-3.30%-0.15%3.77%
2014-3.21%7.67%-0.10%3.32%-0.43%1.88%-3.13%1.94%-2.31%-2.10%3.96%-2.63%4.31%

Expense Ratio

granolas has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of granolas is 3, meaning it’s performing worse than 97% of other portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of granolas is 33
Overall Rank
The Sharpe Ratio Rank of granolas is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of granolas is 22
Sortino Ratio Rank
The Omega Ratio Rank of granolas is 22
Omega Ratio Rank
The Calmar Ratio Rank of granolas is 33
Calmar Ratio Rank
The Martin Ratio Rank of granolas is 33
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
GSK
GlaxoSmithKline plc
-0.45-0.520.94-0.45-0.82
NESN.SW
Nestlé S.A.
0.070.561.070.150.42
ASML
ASML Holding N.V.
-0.37-0.330.95-0.46-0.71
NOVN.SW
Novartis AG
0.470.881.130.651.37
NVO
Novo Nordisk A/S
-1.19-1.870.76-0.87-1.57
MC.PA
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
-0.95-1.220.86-0.66-1.57
AZN.L
AstraZeneca plc
-0.35-0.390.95-0.38-0.66
SAP.DE
SAP SE
1.852.681.332.6711.37
SAN.PA
Sanofi
0.390.771.100.501.06
RMS.PA
Hermès International Société en commandite par actions
0.581.321.171.072.91
RHHBY
Roche Holding AG
0.941.601.220.753.20

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

granolas Sharpe ratios as of May 18, 2025 (values are recalculated daily):

  • 1-Year: -0.13
  • 5-Year: 0.87
  • 10-Year: 0.77
  • All Time: 0.80

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.57 to 1.05, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of granolas compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend yield

granolas provided a 2.70% dividend yield over the last twelve months.


TTM20242023202220212020201920182017201620152014
Portfolio2.70%2.66%2.36%2.50%2.30%2.55%2.43%3.05%2.93%3.40%2.98%3.03%
GSK
GlaxoSmithKline plc
4.30%4.65%3.75%4.78%6.17%6.86%5.34%6.95%7.13%8.84%7.44%7.60%
NESN.SW
Nestlé S.A.
3.53%4.01%3.03%2.61%2.16%2.59%2.34%2.94%2.74%3.08%2.95%2.95%
ASML
ASML Holding N.V.
0.93%0.97%0.85%1.27%0.50%0.59%1.20%1.10%0.75%1.02%0.91%0.77%
NOVN.SW
Novartis AG
3.83%3.72%3.77%3.91%3.94%3.72%3.27%3.98%3.98%4.35%3.58%3.17%
NVO
Novo Nordisk A/S
2.51%1.68%0.99%1.18%1.34%1.86%2.12%2.46%2.13%3.94%1.31%1.96%
MC.PA
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
2.58%2.05%1.70%1.76%0.96%0.90%1.50%2.09%1.71%1.98%2.28%3.58%
AZN.L
AstraZeneca plc
2.38%2.23%2.21%1.98%2.33%2.95%2.87%3.44%4.28%4.50%3.95%3.73%
SAP.DE
SAP SE
0.88%0.93%1.47%2.54%1.48%1.47%1.25%1.61%1.34%1.39%1.50%1.72%
SAN.PA
Sanofi
4.27%4.01%3.97%3.71%3.61%4.00%3.43%4.00%4.12%3.81%3.63%3.70%
RMS.PA
Hermès International Société en commandite par actions
1.01%1.08%0.68%0.55%0.30%0.52%0.68%1.34%0.84%0.86%2.09%0.92%
RHHBY
Roche Holding AG
3.49%3.99%3.55%3.23%2.47%2.63%2.69%3.58%3.22%3.62%3.14%3.23%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the granolas. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the granolas was 38.90%, occurring on Mar 9, 2009. Recovery took 156 trading sessions.

The current granolas drawdown is 9.05%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-38.9%Dec 11, 2007320Mar 9, 2009156Oct 14, 2009476
-24.3%Nov 5, 2021231Sep 26, 202277Jan 12, 2023308
-22.97%Jan 20, 202046Mar 23, 202050Jun 2, 202096
-18.33%Sep 3, 2024153Apr 7, 2025
-16.13%May 20, 2015190Feb 11, 2016120Jul 29, 2016310

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 11 assets, with an effective number of assets of 11.00, reflecting the diversification based on asset allocation. This number of effective assets suggests that the portfolio's investments are spread across a variety of assets, indicating a well-diversified allocation. However, true diversification also depends on the correlations between assets.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

^GSPCNVOASMLRMS.PANESN.SWGSKRHHBYAZN.LSAP.DESAN.PANOVN.SWMC.PAPortfolio
^GSPC1.000.400.650.310.230.440.390.290.390.310.260.410.58
NVO0.401.000.320.220.270.370.370.330.240.280.320.260.55
ASML0.650.321.000.310.210.310.310.240.390.240.220.380.58
RMS.PA0.310.220.311.000.320.200.230.280.480.360.290.670.62
NESN.SW0.230.270.210.321.000.300.440.380.330.380.580.390.58
GSK0.440.370.310.200.301.000.430.500.250.410.410.260.57
RHHBY0.390.370.310.230.440.431.000.400.260.370.500.280.60
AZN.L0.290.330.240.280.380.500.401.000.330.480.520.360.64
SAP.DE0.390.240.390.480.330.250.260.331.000.480.370.600.66
SAN.PA0.310.280.240.360.380.410.370.480.481.000.500.480.67
NOVN.SW0.260.320.220.290.580.410.500.520.370.501.000.380.66
MC.PA0.410.260.380.670.390.260.280.360.600.480.381.000.72
Portfolio0.580.550.580.620.580.570.600.640.660.670.660.721.00
The correlation results are calculated based on daily price changes starting from Dec 2, 2003